PSNL Competitors & Alternatives
Compare Personalis Inc with similar stocks in the same industry
Diagnostics & Research
PSNL
Main Stock$15.71
Tradestie Score
50
Market Cap
$612.76M
Revenue Growth
0.8%
Analyst Upside
-3.5%
Top Competitors
35 stocks in Diagnostics & Research| Company | Price | Market Cap | P/E | Score | Action |
|---|---|---|---|---|---|
|
GRAL
GRAIL, Inc. Common Stock
|
$115.89
|
$2.24B | - | 43 | Compare |
|
ADPT
Adaptive Biotechnologies Corporation Common Stock
|
$29.04
|
$2.22B | - | 40 | Compare |
|
TWST
Twist Bioscience Corporation Common Stock
|
$111.60
|
$1.77B | - | 51 | Compare |
|
NEOG
Neogen Corp
|
$11.23
|
$1.26B | - | 41 | Compare |
|
OPK
Opko Health Inc.
|
$1.68
|
$1.23B | - | 41 | Compare |
|
NEO
NeoGenomics, Inc.
|
$16.02
|
$1.13B | - | 38 | Compare |
|
CDNA
CareDx, Inc.
|
$77.88
|
$798.40M | 33.0 | 29 | Compare |
|
FLGT
Fulgent Genetics, Inc. Common Stock
|
$24.66
|
$719.31M | - | 34 | Compare |
|
MYGN
Myriad Genetics Inc
|
$5.66
|
$719.23M | - | 34 | Compare |
|
CSTL
Castle Biosciences, Inc. Common Stock
|
$33.79
|
$667.77M | - | 46 | Compare |
More PSNL Analysis
Data updated: Nov 13, 2026 | Industry: Diagnostics & Research (SIC 8071)
35 stocks in this industry